Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage

Neurocritical Care

Volumn 3, Issue 3, 2005, Pages 246-248

  Ionita, Catalina C ^a   Ferrara, Joseph ^a   McDonagh, David L ^a   Grossi, Peter ^a   Graffagnino, Carmelo ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Activated factor VII; Intracranial hemorrhage; Intraventricular hemorrhage; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ADULT; ANASTOMOSIS; ANEURYSM; BLOOD CLOT LYSIS; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; BRAIN VENTRICLE; CASE REPORT; CLINICAL FEATURE; COMA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; DECOMPRESSION; DRUG MECHANISM; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; MENTAL HEALTH; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TIME; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING;

ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FACTOR VIIA; FEMALE; FIBRINOLYTIC AGENTS; HEMATOMA; HEMOSTATIC TECHNIQUES; HUMANS; INTRACRANIAL THROMBOSIS; MIDDLE AGED; RECOMBINANT PROTEINS; THALAMUS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WARFARIN;

EID: 29344459620     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:3:3:246     Document Type: Short Survey

References (12)

1. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999;27:617-621.
2. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991;74:81-86.
3. Angelopoulos M, Gupta SR, Azat Kia B. Primary intraventricular hemorrhage in adults: clinical features, risk factors, and outcome. Surg Neurol 1995;44:433-436.
4. Flibotte JJ, Hagan N, O'Donnell J, et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004;63:1059-1064.
5. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004;164:880-884.
6. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular hemorrhage. J Neurol Neurosurg Psychiatry 1995; 58:447-451.
7. Findlay JM, Jacka MJ. Cohort study of intraventricular thromblysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 2004;55:532-538.
8. Shapiro AD, Paola JK, Cohen A, et al. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. Blood 2005;105:518.
9. Freeman DW, Brott GT, Barret MK, et al. Recombinant factor Vila for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004;79:1495-1500.
10. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med 2002;28:S248-S255.
11. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.
12. Naff NJ, Hanley DF, Keyl PM, et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004;54:577-584.